Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Aldape

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Reply to M.C. ChamberlainMark R Gilbert, James Dignam, Stephanie Pugh, et al.
Developmental Cell|August 19, 2009
The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brainXudong Zhao, Domenico D' Arca, Wei Keat Lim, et al.
Neuro-Oncology|March 19, 2013
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysisYong-Wan Kim, Dimpy Koul, Se Hoon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastomaLiliana Soroceanu, Samir Kharbanda, Ruihuan Chen, et al.
Cancer Research|April 3, 2003
Genetic determinants of malignancy in a mouse model for oligodendrogliomaWilliam A Weiss, Michael J Burns, Christopher Hackett, et al.
Journal of the Neurological Sciences|May 31, 2022
Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on managementRachel Woodford, Lyndsey Prather, Cassandra Helfer, et al.
Blood|January 19, 2006
Gene expression and angiotropism in primary CNS lymphomaJames L Rubenstein, Jane Fridlyand, Arthur Shen, et al.
The Journal of Clinical Investigation|December 18, 2012
Mesenchymal high-grade glioma is maintained by the ID-RAP1 axisFrancesco Niola, Xudong Zhao, Devendra Singh, et al.
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Reply to M.C. ChamberlainMark R Gilbert, James Dignam, Stephanie Pugh, et al.
Developmental Cell|August 19, 2009
The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brainXudong Zhao, Domenico D' Arca, Wei Keat Lim, et al.
Neuro-Oncology|March 19, 2013
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysisYong-Wan Kim, Dimpy Koul, Se Hoon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastomaLiliana Soroceanu, Samir Kharbanda, Ruihuan Chen, et al.
Cancer Research|April 3, 2003
Genetic determinants of malignancy in a mouse model for oligodendrogliomaWilliam A Weiss, Michael J Burns, Christopher Hackett, et al.
Journal of the Neurological Sciences|May 31, 2022
Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on managementRachel Woodford, Lyndsey Prather, Cassandra Helfer, et al.
Blood|January 19, 2006
Gene expression and angiotropism in primary CNS lymphomaJames L Rubenstein, Jane Fridlyand, Arthur Shen, et al.
The Journal of Clinical Investigation|December 18, 2012
Mesenchymal high-grade glioma is maintained by the ID-RAP1 axisFrancesco Niola, Xudong Zhao, Devendra Singh, et al.
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Pageof 6